{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:32:56Z","timestamp":1793406776269,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.aohep.2020.06.010","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T21:38:55Z","timestamp":1595281135000},"page":"100224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"special_numbering":"C","title":["STAT3: A key regulator in liver fibrosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Jie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Fen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.aohep.2020.06.010_bib0005","first-page":"875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.aohep.2020.06.010_bib0010","first-page":"14","article-title":"Liver fibrosis","volume":"29","author":"Aydin","year":"2018","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.06.010_bib0015","article-title":"Intercellular crosstalk of hepatic stellate cells in liver fibrosis: new insights into therapy","volume":"155","author":"Cai","year":"2020","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.aohep.2020.06.010_bib0020","first-page":"430","article-title":"STAT proteins \u2014 key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver","volume":"57","author":"Gao","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2020.06.010_bib0025","first-page":"55","article-title":"JAK\/STAT \u2014 emerging players in metabolism","volume":"29","author":"Dodington","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.aohep.2020.06.010_bib0030","article-title":"Revisiting the development of small molecular inhibitors that directly target the signal transducer and activator of transcription 3 (STAT3) domains","volume":"242","author":"Shih","year":"2020","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.aohep.2020.06.010_bib0035","first-page":"1","article-title":"Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment","volume":"19","author":"Kasembeli","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.aohep.2020.06.010_bib0040","first-page":"536","article-title":"Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target","volume":"7","author":"Wang","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2020.06.010_bib0045","first-page":"25","article-title":"STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib","volume":"46","author":"Deng","year":"2013","journal-title":"J Autoimmun"},{"issue":"9","key":"10.1016\/j.aohep.2020.06.010_bib0050","first-page":"651","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"17","key":"10.1016\/j.aohep.2020.06.010_bib0055","first-page":"2520","article-title":"Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production","volume":"25","author":"Ogata","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.aohep.2020.06.010_bib0060","first-page":"1596","article-title":"ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6\/JAK\/STAT3 signaling pathway","volume":"10","author":"Shen","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.aohep.2020.06.010_bib0065","first-page":"33","article-title":"Mechanisms of hepatitis B virus persistence","volume":"26","author":"Tsai","year":"2018","journal-title":"Trends Microbiol"},{"issue":"7","key":"10.1016\/j.aohep.2020.06.010_bib0070","first-page":"1","article-title":"HoxA10 facilitates SHP-1-catalyzed dephosphorylation of p38 MAPK\/STAT3 to repress hepatitis B virus replication by a feedback regulatory mechanism","volume":"93","author":"Yang","year":"2019","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.aohep.2020.06.010_bib0075","first-page":"48","article-title":"Hepatitis B virus replication","volume":"13","author":"Beck","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.06.010_bib0080","first-page":"651","article-title":"The molecular biology of the hepatitis B viruses","volume":"56","author":"Ganem","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.aohep.2020.06.010_bib0085","first-page":"37","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"63","author":"Parola","year":"2018","journal-title":"Mol Aspects Med"},{"issue":"6","key":"10.1016\/j.aohep.2020.06.010_bib0090","first-page":"2721","article-title":"Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function","volume":"76","author":"Waris","year":"2002","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.aohep.2020.06.010_bib0095","first-page":"987","article-title":"STAT3 directly regulates NKp46 transcription in NK cells of HBeAg-negative CHB patients","volume":"106","author":"Zheng","year":"2019","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1016\/j.aohep.2020.06.010_bib0100","first-page":"7416","article-title":"Effect of modified Xiaochaihu decoctioncontaining serum on HepG2.2.15 cells via the JAK2\/STAT3 signaling pathway","volume":"16","author":"Chen","year":"2017","journal-title":"Mol Med Rep"},{"issue":"47","key":"10.1016\/j.aohep.2020.06.010_bib0105","first-page":"39589","article-title":"Beta-catenin activates the HOXA10 and CDX4 genes in myeloid progenitor cells","volume":"287","author":"Bei","year":"2012","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.aohep.2020.06.010_bib0110","first-page":"1545","article-title":"Synergistic effect of radiation and interleukin-6 on hepatitis B virus reactivation in liver through STAT3 signaling pathway","volume":"75","author":"Chou","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.aohep.2020.06.010_bib0115","first-page":"16","article-title":"Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression","volume":"7","author":"Xiong","year":"2017","journal-title":"Cell Biosci"},{"issue":"6","key":"10.1016\/j.aohep.2020.06.010_bib0120","first-page":"1123","article-title":"miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator","volume":"75","author":"Yamashita","year":"2015","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.aohep.2020.06.010_bib0125","first-page":"4873","article-title":"Polarization of monocytic myeloid-derived suppressor sells by hepatitis B surface antigen is mediated via ERK\/IL-6\/STAT3 signaling feedback and restrains the activation of T cells in chronic hepatitis B virus infection","volume":"195","author":"Fang","year":"2015","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.aohep.2020.06.010_bib0130","first-page":"799","article-title":"Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor","volume":"50","author":"Hoechst","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2020.06.010_bib0135","first-page":"112","article-title":"Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent","volume":"6","author":"Choudhari","year":"2007","journal-title":"Atiprimod. Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.aohep.2020.06.010_bib0140","first-page":"407","article-title":"Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: current concepts and perspectives","volume":"50","author":"Arab","year":"2020","journal-title":"Hepatol Res"},{"issue":"39","key":"10.1016\/j.aohep.2020.06.010_bib0145","first-page":"11077","article-title":"Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance","volume":"21","author":"Stal","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2020.06.010_bib0150","first-page":"20","article-title":"Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway","volume":"510","author":"Li","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.aohep.2020.06.010_bib0155","first-page":"6298","article-title":"Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver disease via IL-22-mediated JAK1\/STAT3\/BAX signaling","volume":"9","author":"Zhu","year":"2018","journal-title":"Food Funct"},{"key":"10.1016\/j.aohep.2020.06.010_bib0160","first-page":"1649","article-title":"The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway","volume":"10","author":"Zhu","year":"2016","journal-title":"Drug Des Devel Ther"},{"issue":"7","key":"10.1016\/j.aohep.2020.06.010_bib0165","first-page":"1","article-title":"Kahweol ameliorates the liver inflammation through the inhibition of NF-kappaB and STAT3 activation in primary Kupffer cells and primary hepatocytes","volume":"10","author":"Seo","year":"2018","journal-title":"Nutrients"},{"issue":"18","key":"10.1016\/j.aohep.2020.06.010_bib0170","first-page":"5537","article-title":"Multifunctional efects of a small-molecule STAT3 inhibitor on NASH and hepatocellular carcinoma in mice","volume":"23","author":"Jung","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.aohep.2020.06.010_bib0175","first-page":"1","article-title":"Stanniocalcin 2 ameliorates hepatosteatosis through activation of STAT3 signaling","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.aohep.2020.06.010_bib0180","first-page":"168","article-title":"Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo","volume":"10","author":"Inoue","year":"2004","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.aohep.2020.06.010_bib0185","first-page":"846","article-title":"Inflammation-associated interleukin-6\/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice","volume":"54","author":"Miller","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2020.06.010_bib0190","first-page":"1291","article-title":"Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3","volume":"52","author":"Ki","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2020.06.010_bib0195","first-page":"339","article-title":"Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22","volume":"53","author":"Yang","year":"2010","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2020.06.010_bib0200","first-page":"1","article-title":"Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation","volume":"12","author":"Kagan","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.aohep.2020.06.010_bib0205","first-page":"794","article-title":"Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease","volume":"308","author":"Min","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.aohep.2020.06.010_bib0210","first-page":"184","article-title":"Betulinic acid and betulin ameliorate acute ethanol-induced fatty liver via TLR4 and STAT3 in vivo and in vitro","volume":"17","author":"Min","year":"2013","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.aohep.2020.06.010_bib0215","first-page":"92","article-title":"Cytokines, STATs and liver disease","volume":"2","author":"Gao","year":"2005","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"10.1016\/j.aohep.2020.06.010_bib0220","first-page":"1724","article-title":"Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice","volume":"51","author":"Horiguchi","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2020.06.010_bib0225","first-page":"69","article-title":"Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2\/STAT3 pathways","volume":"37","author":"Zheng","year":"2009","journal-title":"Am J Chin Med"},{"issue":"2","key":"10.1016\/j.aohep.2020.06.010_bib0230","first-page":"91","article-title":"gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis","volume":"15","author":"Bollrath","year":"2009","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.aohep.2020.06.010_bib0235","first-page":"798","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"9936","key":"10.1016\/j.aohep.2020.06.010_bib0240","first-page":"2253","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.aohep.2020.06.010_bib0245","first-page":"296","article-title":"IL-9 blockage reduces early hepatic granuloma formation and fibrosis during Schistosoma japonicum infection in mice","volume":"158","author":"Zhan","year":"2019","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.aohep.2020.06.010_bib0250","first-page":"433","article-title":"Human schistosomiasis: clinical perspective: review","volume":"4","author":"Barsoum","year":"2013","journal-title":"J Adv Res"},{"key":"10.1016\/j.aohep.2020.06.010_bib0255","first-page":"1","article-title":"Schistosoma mansoni egg-secreted antigens activate hepatocellular carcinoma-associated transcription factors c-Jun and STAT3 in hamster and human hepatocytes","volume":"0","author":"Roderfeld","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.aohep.2020.06.010_bib0260","first-page":"542","article-title":"Schistosoma mansoni infection: is it a risk factor for development of hepatocellular carcinoma?","volume":"128","author":"Roderfeld","year":"2013","journal-title":"Acta Trop"},{"issue":"12","key":"10.1016\/j.aohep.2020.06.010_bib0265","first-page":"4716","article-title":"A Schistosoma japonicum infection promotes the expansion of myeloid-derived suppressor cells by activating the JAK\/STAT3 pathway","volume":"198","author":"Yang","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.aohep.2020.06.010_bib0270","first-page":"339","article-title":"MicroR-146 blocks the activation of M1 macrophage by targeting signal transducer and activator of transcription 1 in hepatic schistosomiasis","volume":"13","author":"Yang","year":"2016","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.aohep.2020.06.010_bib0275","first-page":"159","article-title":"MicroRNAs in NF-kappaB signaling","volume":"3","author":"Ma","year":"2011","journal-title":"J Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.aohep.2020.06.010_bib0280","first-page":"215","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.aohep.2020.06.010_bib0285","first-page":"1","article-title":"Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells by activation of the STAT3\/p53\/p21 pathway","volume":"7","author":"Chen","year":"2016","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.aohep.2020.06.010_bib0290","first-page":"1150","article-title":"Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.06.010_bib0295","first-page":"1","article-title":"Molecular mechanisms underlying chemical liver injury","volume":"14","author":"Gu","year":"2012","journal-title":"Expert Rev Mol Med"},{"issue":"4","key":"10.1016\/j.aohep.2020.06.010_bib0300","first-page":"561","article-title":"Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis","volume":"41","author":"Dong","year":"2016","journal-title":"J Toxicol Sci"},{"issue":"1","key":"10.1016\/j.aohep.2020.06.010_bib0305","first-page":"49","article-title":"A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice","volume":"513","author":"Choi","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"issue":"102","key":"10.1016\/j.aohep.2020.06.010_bib0310","first-page":"100652","article-title":"STAT3 inhibition suppresses hepatic stellate cell fibrogenesis: HJC0123, a potential therapeutic agent for liver fibrosis","volume":"6","author":"Nunez Lopez","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.aohep.2020.06.010_bib0315","first-page":"165","article-title":"Activation of BK channels prevents hepatic stellate cell activation and liver fibrosis through the suppression of TGF\u03b21\/SMAD3 and JAK\/STAT3 profibrotic signaling pathways","volume":"11","author":"Yang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.aohep.2020.06.010_bib0320","first-page":"184","article-title":"CCM111 prevents hepatic fibrosis via cooperative inhibition of TGF-beta, Wnt and STAT3 signaling pathways","volume":"27","author":"Lin","year":"2019","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.aohep.2020.06.010_bib0325","first-page":"3595","article-title":"Asiatic acid ameliorates CCl4-induced liver fibrosis in rats: involvement of Nrf2\/ARE, NF-kappaB\/IkappaBalpha, and JAK1\/STAT3 signaling pathways","volume":"12","author":"Fan","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.aohep.2020.06.010_bib0330","first-page":"1","article-title":"Asiatic acid exhibits anti-inflammatory and antioxidant activities against lipopolysaccharide and d-galactosamine-induced fulminant hepatic failure","volume":"8","author":"Lv","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.aohep.2020.06.010_bib0335","first-page":"1297","article-title":"Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin BLM via suppressing pro-fibrotic and inflammatory signaling pathways","volume":"89","author":"Dong","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.aohep.2020.06.010_bib0340","first-page":"1337","article-title":"S-allyl-cysteine attenuates carbon tetrachloride-induced liver fibrosis in rats by targeting STAT3\/SMAD3 pathway","volume":"10","author":"Gong","year":"2018","journal-title":"Am J Transl Res"},{"issue":"10","key":"10.1016\/j.aohep.2020.06.010_bib0345","first-page":"4302","article-title":"Transforming growth factor-beta TGF-beta directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway","volume":"292","author":"Tang","year":"2017","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.aohep.2020.06.010_bib0350","first-page":"31","article-title":"Relationship between anti-fibrotic effect of panax notoginseng saponins and serum cytokines in rat hepatic fibrosis","volume":"388","author":"Peng","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.aohep.2020.06.010_bib0355","first-page":"217","article-title":"Panax notoginseng saponins ameliorates experimental hepatic fibrosis and hepatic stellate cell proliferation by inhibiting the Jak2\/ Stat3 pathways","volume":"36","author":"Hui","year":"2016","journal-title":"J Tradit Chin Med"},{"issue":"10","key":"10.1016\/j.aohep.2020.06.010_bib0360","first-page":"1","article-title":"Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6\/STAT3 signaling pathway in CCl4-induced rat liver fibrosis","volume":"13","author":"Farouk","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.aohep.2020.06.010_bib0365","first-page":"885","article-title":"Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?","volume":"75","author":"Kia","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.aohep.2020.06.010_bib0370","first-page":"276","article-title":"Differentiation of bone marrow: derived mesenchymal stem cells into hepatocyte-like cells","volume":"32","author":"Al Ghrbawy","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"5","key":"10.1016\/j.aohep.2020.06.010_bib0375","first-page":"1418","article-title":"Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices","volume":"54","author":"Sharma","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.aohep.2020.06.010_bib0380","first-page":"203","article-title":"Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2\/STAT3 signaling in hepatic stellate cells","volume":"49","author":"Lu","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.aohep.2020.06.010_bib0385","article-title":"Interleukin-10 induces senescence of activated hepatic stellate cells via STAT3-p53 pathway to attenuate liver fibrosis","volume":"66","author":"Huang","year":"2020","journal-title":"Cell Signal"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:41:53Z","timestamp":1761648113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268120300715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":77,"alternative-id":["S1665268120300715"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2020.06.010","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT3: A key regulator in liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2020.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100224"}}